These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23452506)

  • 41. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
    Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
    Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial.
    Staring AB; Van der Gaag M; Koopmans GT; Selten JP; Van Beveren JM; Hengeveld MW; Loonen AJ; Mulder CL
    Br J Psychiatry; 2010 Dec; 197(6):448-55. PubMed ID: 21119150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
    Schoemaker JH; Jansen WT; Schipper J; Szegedi A
    J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M; Mayr A; Seemüller F; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Schennach-Wolff R
    World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical correlates of early medication adherence: West London first episode schizophrenia study.
    Mutsatsa SH; Joyce EM; Hutton SB; Webb E; Gibbins H; Paul S; Barnes TR
    Acta Psychiatr Scand; 2003 Dec; 108(6):439-46. PubMed ID: 14616225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.
    Tarrier N; Lewis S; Haddock G; Bentall R; Drake R; Kinderman P; Kingdon D; Siddle R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Dunn G
    Br J Psychiatry; 2004 Mar; 184():231-9. PubMed ID: 14990521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial.
    Gray R; Wykes T; Edmonds M; Leese M; Gournay K
    Br J Psychiatry; 2004 Aug; 185():157-62. PubMed ID: 15286068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial attitudes toward a drug predict medication adherence in first-episode patients with schizophrenia: a 1-year prospective study in China.
    Dai N; Huang B; Gao T; Zheng Y; Shi C; Pu C; Yu X
    BMC Psychiatry; 2023 Dec; 23(1):907. PubMed ID: 38053101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of Adherence Therapy for People With Schizophrenia in Turkey: A Controlled Study.
    Dikec G; Kutlu Y
    Arch Psychiatr Nurs; 2016 Apr; 30(2):249-56. PubMed ID: 26992879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supervised treatment in outpatients for schizophrenia plus (STOPS+): protocol for a cluster randomised trial of a community-based intervention to improve treatment adherence and reduce the treatment gap for schizophrenia in Pakistan.
    Shepherd TA; Ul-Haq Z; Ul-Haq M; Khan MF; Afridi A; Dikomitis L; Robinson ME; Lewis M; Rahman A; Dziedzic K; Saeed U; Awan NR; Mallen C; Farooq S
    BMJ Open; 2020 Jun; 10(6):e034709. PubMed ID: 32606055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Family education for people with schizophrenia in Beijing, China: randomised controlled trial.
    Li Z; Arthur D
    Br J Psychiatry; 2005 Oct; 187():339-45. PubMed ID: 16199793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia.
    Glick ID; Stekoll AH; Hays S
    J Clin Psychopharmacol; 2011 Feb; 31(1):82-5. PubMed ID: 21192148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In response to the Commentary to our systematic review 'Does adherence therapy improve medication adherence among patients with schizophrenia?'.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2015 Aug; 24(4):373-4. PubMed ID: 26245521
    [No Abstract]   [Full Text] [Related]  

  • 59. Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia.
    Lauriello J; Perkins DO
    J Clin Psychiatry; 2019 Mar; 80(2):. PubMed ID: 30920189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomised controlled trial of a treatment adherence programme for prisoners with mental health problems in Spain.
    Muela A; Aliri J; Presa B; Gorostiaga A
    Crim Behav Ment Health; 2020 Feb; 30(1):6-15. PubMed ID: 32173950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.